Multimedialna platforma wiedzy medycznej Internetowa Księgarnia Medyczna Kalendarium Konferencji
Advances in Respiratory Medicine
MENU
Shortcuts Submit an article Guide for Authors Ahead Of Print Author statement Editorial Policy and Information for Authors Reviewers 2020

open access

Vol 77, No 2 (2009)
Case report
Submitted: 2013-02-22
Published online: 2009-03-16
View PDF Download PDF file
Get Citation

Combined pulmonary fibrosis and emphysema - case report and literature review

Monika Kosacka, Anna Brzecka, Renata Jankowska, Jerzy Lewczuk, Ewa Mroczek, Bożena Weryńska
Pneumonol Alergol Pol 2009;77(2):205-210.

open access

Vol 77, No 2 (2009)
CASE REPORTS
Submitted: 2013-02-22
Published online: 2009-03-16

Abstract

We describe the case of a 61-year-old male patient, in which the search for the cause of chronic respiratory failure, severe pulmonary hypertension and secondary erythrocytosis resulted in a diagnosis of combined pulmonary fibrosis and emphysema (CPFE). This is a unique, recently characterised syndrome with upper-lobe emphysema and pulmonary fibrosis of the lower lungs. The cause is unknown, but one of the main risk factor remains smoking. The patient was a heavy smoker (over 40 pack-years). He complained of dyspnoea on exertion and cough. Physical examination revealed basal crackles and cyanosis. The patient had severe reduction in diffusing capacity, out of proportion to his lung volumes (DLCO 27% of predicted value, FEV1 2.95 l (100%), FVC 4.41 l (118%), FEV1/FVC (66%). The blood gas showed hypoxemia (pO2 37 mm Hg), hypocapnia and respiratory alkalosis. Diagnosis was based on chest computer tomography, which revealed upper lobe emphysema and lower lobe ground glass changes and honeycombing. Severe pulmonary hypertension (SPAP 80 mm Hg) was confirmed by echocardiography and right cardiac catherisation. The patient received long-term oxygen therapy, inhaled corticosteroid and Ca-blocker.

Abstract

We describe the case of a 61-year-old male patient, in which the search for the cause of chronic respiratory failure, severe pulmonary hypertension and secondary erythrocytosis resulted in a diagnosis of combined pulmonary fibrosis and emphysema (CPFE). This is a unique, recently characterised syndrome with upper-lobe emphysema and pulmonary fibrosis of the lower lungs. The cause is unknown, but one of the main risk factor remains smoking. The patient was a heavy smoker (over 40 pack-years). He complained of dyspnoea on exertion and cough. Physical examination revealed basal crackles and cyanosis. The patient had severe reduction in diffusing capacity, out of proportion to his lung volumes (DLCO 27% of predicted value, FEV1 2.95 l (100%), FVC 4.41 l (118%), FEV1/FVC (66%). The blood gas showed hypoxemia (pO2 37 mm Hg), hypocapnia and respiratory alkalosis. Diagnosis was based on chest computer tomography, which revealed upper lobe emphysema and lower lobe ground glass changes and honeycombing. Severe pulmonary hypertension (SPAP 80 mm Hg) was confirmed by echocardiography and right cardiac catherisation. The patient received long-term oxygen therapy, inhaled corticosteroid and Ca-blocker.

Full Text:

View PDF Download PDF file
Get Citation

Keywords

combined pulmonary fibrosis and emphysema; pulmonary hypertension; chronic respiratory failure

About this article
Title

Combined pulmonary fibrosis and emphysema - case report and literature review

Journal

Advances in Respiratory Medicine

Issue

Vol 77, No 2 (2009)

Article type

Case report

Pages

205-210

Published online

2009-03-16

Bibliographic record

Pneumonol Alergol Pol 2009;77(2):205-210.

Keywords

combined pulmonary fibrosis and emphysema
pulmonary hypertension
chronic respiratory failure

Authors

Monika Kosacka
Anna Brzecka
Renata Jankowska
Jerzy Lewczuk
Ewa Mroczek
Bożena Weryńska

References (18)
  1. Wiggins J, Strickland B, Turner-Warwick M. Combined cryptogenic fibrosing alveolitis and emphysema: the value of high resolution computed tomography in assessment. Respir Med. 1990; 84(5): 365–369.
    PubMed
  2. Lim TK. Respiratory failure from combined emphysema and pulmonary fibrosis. Singapore Med J. 1993; 34(2): 169–171.
    PubMed
  3. Grubstein A, Bendayan D, Schactman I, et al. Concomitant upper-lobe bullous emphysema, lower-lobe interstitial fibrosis and pulmonary hypertension in heavy smokers: report of eight cases and review of the literature. Respir Med. 2005; 99(8): 948–954.
    CrossRefPubMed
  4. Jankowich MD, Polsky M, Klein M, et al. Heterogeneity in combined pulmonary fibrosis and emphysema. Respiration. 2008; 75(4): 411–417.
    CrossRefPubMed
  5. Cottin V, Nunes H, Brillet PY, et al. Groupe d'Etude et de Recherche sur les Maladies Orphelines Pulmonaires (GERM O P). Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity. Eur Respir J. 2005; 26(4): 586–593.
    CrossRefPubMed
  6. Cottin V, Brillet PY, Nunes H, et al. Groupe d'étude et de recherche sur les maladies "orphelines" pulmonaires (GERM"O"P). [Combined pulmonary fibrosis and emphysema]. Presse Med. 2007; 36(6 Pt 2): 936–944.
    CrossRefPubMed
  7. Rogliani P, Mura M, Mattia P, et al. HRCT and histopathological evaluation of fibrosis and tissue destruction in IPF associated with pulmonary emphysema. Respir Med. 2008; 102(12): 1753–1761.
    CrossRefPubMed
  8. Wesołowski S, Oniszh K, Kuś J. Znaczenie kliniczne typu zmian w obrazie tomografii komputerowej wysokiej rozdzielczości u chorych na samoistne włóknienie płuc. Pneumonol Alergol Pol. 2000; 68: 434–440.
  9. Bestry I, Oniszh K, Pawlicka L, Dobkowski P. Rola metod obrazowych w diagnostyce śródmiąższowych chorób płuc. In: Rowińska-Zakrzewska E, Wiatr E, Pirożyński M. ed. Choroby śródmiąższowe płuc. a-medica press 2001: 24–67.
  10. Lewczuk J. Nadciśnienie płucne w śródmiąższowych chorobach płuc. Pneumonol Alergol Pol. 2007; 75: 153–157.
  11. Lettieri CJ, Nathan SD, Barnett SD, et al. Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis. Chest. 2006; 129(3): 746–752.
    CrossRefPubMed
  12. Nathan SD, Shlobin OA, Weir N, et al. Pulmonary hypertension and pulmonary function testing in idiopathic pulmonary fibrosis. Chest. 2007; 131(3): 657–663.
    CrossRefPubMed
  13. Hamada K, Nagai S, Tanaka S, et al. Significance of pulmonary arterial pressure and diffusion capacity of the lung as prognosticator in patients with idiopathic pulmonary fibrosis. Chest. 2007; 131(3): 650–656.
    CrossRefPubMed
  14. Schachna L, Medsger TA, Dauber JH, et al. Age and risk of pulmonary arterial hypertension in scleroderma. Chest. 2003; 124(6): 2098–2104.
    PubMed
  15. Weitzenblum E, Chaouat A, Kessler R, et al. Overlap syndrome: obstructive sleep apnea in patients with chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2008; 5(2): 237–241.
    CrossRefPubMed
  16. Brzecka A. Przyczyny wtórnej erytrocytozy u chorych z zespołem obturacyjnego bezdechu śródsennego. Adv Clin Exp Med. 2001; 10: 133–138.
  17. Daniil Z, Koutsokera A, Gourgoulianis K. Combined pulmonary fibrosis and emphysema in patients exposed to agrochemical compounds. Eur Respir J. 2006; 27(2): 434.
    CrossRefPubMed
  18. Lundblad LKA, Thompson-Figueroa J, Leclair T, et al. Tumor necrosis factor-alpha overexpression in lung disease: a single cause behind a complex phenotype. Am J Respir Crit Care Med. 2005; 171(12): 1363–1370.
    CrossRefPubMed

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Czasopismo Pneumonologia i Alergologia Polska dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl